Abstract
Zafirlukast and placebo were administered orally as individual agents to 20 dogs with atopic dermatitis. The pruritus was effectively reduced by at least 50% in 2/18 (11%) dogs that completed the trial with zafirlukast. Two dogs vomited after administration of the active drug.
Publication types
-
Clinical Trial
-
Controlled Clinical Trial
MeSH terms
-
Administration, Oral
-
Animals
-
Cross-Over Studies
-
Dermatitis, Atopic / drug therapy
-
Dermatitis, Atopic / veterinary*
-
Dog Diseases / drug therapy*
-
Dogs
-
Female
-
Indoles
-
Leukotriene Antagonists / therapeutic use*
-
Male
-
Phenylcarbamates
-
Single-Blind Method
-
Sulfonamides
-
Tosyl Compounds / therapeutic use*
-
Treatment Outcome
Substances
-
Indoles
-
Leukotriene Antagonists
-
Phenylcarbamates
-
Sulfonamides
-
Tosyl Compounds
-
zafirlukast